Screener/Healthcare/Biotechnology

DNTH

Dianthus Therapeutics, Inc.NASDAQ
$79.65+0.33 (+0.42%)
Mid CapHealthcare
$13.37
$88.02
$76.42
$80.28
EPS (TTM)$-3.49
P/E Ratio—
Dividend Yield—
Market Cap$2.84B
Volume513K
Prev Close$79.32
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$396K-$36.8M$-0.97—-9284.1%
Q2 '25$193K-$31.6M$-0.88—-16388.1%
Q1 '25$1.2M-$29.5M$-0.82—-2537.5%
Q4 '24$1.3M-$28.4M$-0.82—-2144.8%
Q3 '24$2.2M-$25.2M$-0.74—-1159.0%
Q2 '24$1.9M-$17.6M$-0.51—-945.1%
Q1 '24$874K-$13.7M$-0.54—-1573.0%
Q3 '23$924K-$14.8M$-3.78—-1597.7%
Get Your Daily Market Recap